Executive Vice President
Optimal Strategix Group, USA
Steve Lehrer is an Executive Vice President and Leader of the Life Sciences Practice at Optimal Strategix Group. Steve has over 25 years of experience starting, growing and running life science based businesses focused on commercializing new technology. Steve has extensive experience in biosimilars and led efforts at developing and commercializing biosimilars at four different pharmaceutical companies during the past 20 years. His experience covers R&D, regulator, manufacturing, pricing, reimbursement and commercial marketing. In addition, Mr. Lehrer has performed due diligence on several biosimilar opportunities. Mr. Lehrer currently sits on the Board of 2 life science companies and provides strategy advise to several CEO/senior management teams on a wide range of topics from commercial strategy through operations /business development and portfolio planning. Steve has a Master’s Degree from The Graduate School of Business at Harvard University and a BSE in Chemical Engineering and a BA in Economics from the University of Maryland, College Park.